In addition, while exploring alternative treatments and information for cSCC, it is important to acknowledge the limitation posed by the absence of using PDL-1 Inhibitors or tyrosine kinase inhibitors, which are currently not used in the treatment of cSCC. Here, CD274 is linked to skin squamous cell carcinoma.